Evidence map›Paper›PMID 18160429›Full record

ArticleJournal of virology2008

Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Sylvain Huard, Robert T Elder, Dong Liang, Ge Li, Richard Y Zhao

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Contribution of yeast models to virus research.Applied microbiology and biotechnology · 2021
    Review
  3. Review
  4. Breaking Bad: How Viruses Subvert the Cell Cycle.Frontiers in cellular and infection microbiology · 2018
    Review
  5. Yeast for virus research.Microbial cell (Graz, Austria) · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sylvain HuardDepartment of Pathology, University of Maryland School of Medicine, 10 South Pine Street, MSTF700A, Baltimore, MD 21201, USA.
Robert T Elder
Dong Liang
Ge Li
Richard Y Zhao
Northwestern University · USUniversity of Maryland, Baltimore · US

Funding

Effect of HIV-1 Vpr on Basic Cellular Functions (II)R01AI040891 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ZHAO, RICHARD YUQI · 2003 to 2007
$1.4M
Cell Cycle G2/M Pathway Modulated by Viral Protein RR01GM063080 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ZHAO, RICHARD YUQI · 2002 to 2006
$968k
Effect of HIV-1 Vpr on Basic Cellular FunctionsR21AI040891 · NIAID · CHILDREN'S MEMORIAL HOSPITAL (CHICAGO) · PI ZHAO, RICHARD YUQI · 2002 to 2002
$249k
HIV-1 VPR AND BASIC CELLULAR FUNCTIONSR29AI040891 · NIAID · CHILDREN'S MEMORIAL HOSPITAL (CHICAGO) · PI ZHAO, RICHARD YUQI · 1997 to 2001
$209k
NIAID NIH HHS AI40891NIAID NIH HHS R01 AI040891NIAID NIH HHS R21 AI040891NIAID NIH HHS R29 AI040891NIGMS NIH HHS GM63080NIGMS NIH HHS R01 GM063080
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) Vpr induces cell cycle G(2) arrest in fission yeast (Schizosaccharomyces pombe) and mammalian cells, suggesting the cellular pathway(s) targeted by Vpr is conserved among eukaryotes. Our previous studies in fission yeast demonstrated that Vpr induces G(2) arrest in part through inhibition of Cdc25, a Cdc2-specific phosphatase that promotes G(2)/M transition. The goal of this study was to further elucidate molecular mechanism underlying the inhibitory effect of Vpr on Cdc25. We show here that, similar to the DNA checkpoint controls, expression of vpr promotes subcellular relocalization of Cdc25 from nuclear to cytoplasm and thereby prevents activation of Cdc2 by Cdc25. Vpr-induced nuclear exclusion of Cdc25 appears to depend on the serine/threonine phosphorylation of Cdc25 and the presence of Rad24/14-3-3 protein, since amino acid substitutions of the nine possible phosphorylation sites of Cdc25 with Ala (9A) or deletion of the rad24 gene abolished nuclear exclusion induced by Vpr. Interestingly, Vpr is still able to promote Cdc25 nuclear export in mutants defective in the checkpoints (rad3 and chk1/cds1), the kinases that are normally required for Cdc25 phosphorylation and nuclear exclusion of Cdc25, suggesting that others kinase(s) might modulate phosphorylation of Cdc25 for the Vpr-induced G(2) arrest. We report here that this kinase is Srk1. Deletion of the srk1 gene blocks the nuclear exclusion of Cdc25 caused by Vpr. Overexpression of srk1 induces cell elongation, an indication of cell cycle G(2) delay, in a similar fashion to Vpr; however, no additive effect of cell elongation was observed when srk1 and vpr were coexpressed, indicating Srk1 and Vpr are likely affecting the cell cycle G(2)/M transition through the same cellular pathway. Immunoprecipitation further shows that Vpr and Srk1 are part of the same protein complex. Consistent with our findings in fission yeast, depletion of the MK2 gene, a human homologue of Srk1, either by small interfering RNA or an MK2 inhibitor suppresses Vpr-induced cell cycle G(2) arrest in mammalian cells. Collectively, our data suggest that Vpr induces cell cycle G(2) arrest at least in part through a Srk1/MK2-mediated mechanism.

Indexed as

G2 PhaseCell CompartmentationCell Cycle ProteinsCell LineCytoplasmFungal ProteinsGene Products, vprHIV-1HumansMitogen-Activated Protein KinasesPhosphorylationras-GRF1SchizosaccharomycesSchizosaccharomyces pombe ProteinsCell Cycle ProteinsFungal ProteinsGene Products, vprMitogen-Activated Protein Kinasesras-GRF1Schizosaccharomyces pombe ProteinsSRK1 protein, S pombe

Identifiers

PMID18160429
PMCPMC2259012
OpenAlexW2029153089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.